TAYMANS JILL M 4
4 · CRYO CELL INTERNATIONAL INC · Filed Jan 9, 2026
Insider Transaction Report
Form 4
TAYMANS JILL M
VP Finance, CFO
Transactions
- Award
Stock Option
2026-01-07$3.54/sh+10,000$35,400→ 10,000 totalExercise: $3.54From: 2026-01-07Exp: 2031-01-07→ Common Stock (10,000 underlying) - Award
Stock Option
2026-01-07$3.54/sh+20,000$70,800→ 20,000 totalExercise: $3.54From: 2026-01-07Exp: 2031-01-07→ Common Stock (20,000 underlying)
Holdings
- 45,396
Common Stock
- 7,500
Stock Option
Exercise: $3.10From: 2019-06-02Exp: 2026-06-02→ Common Stock (7,500 underlying) - 7,000
Stock Option
Exercise: $8.00From: 2020-09-23Exp: 2027-09-23→ Common Stock (7,000 underlying) - 20,000
Stock Option
Exercise: $4.62From: 2023-01-13Exp: 2028-01-13→ Common Stock (20,000 underlying) - 10,000
Stock Option
Exercise: $5.88From: 2023-12-22Exp: 2028-12-22→ Common Stock (10,000 underlying) - 10,000
Stock Option
Exercise: $7.35From: 2025-01-21Exp: 2030-01-21→ Common Stock (10,000 underlying)
Footnotes (5)
- [F1]Stock options vest 1/5 per year commencing on September 23, 2020.
- [F2]Stock options vest 1/3 upon issuance, 1/3 on December 22, 2024 and 1/3 on December 22, 2025.
- [F3]Stock options vest 1/3 upon issuance, 1/3 on January 22, 2026 and 1/3 on January 22, 2027.
- [F4]Stock options vest 1/3 upon issuance, 1/3 on January 7, 2027 and 1/3 on January 7, 2028.
- [F5]The stock options were granted pursuant to the Cryo-Cell 2022 Stock Incentive Plan and an individual award agreement. The options are divided into three equal tranches, each subject to both time-based vesting and stock-price performance conditions. One tranche vests after the first anniversary of the grant date and upon the Company's common stock achieving an average closing price of at least $6 per share over 20 consecutive trading days. One tranche vests after the second anniversary and upon achieving an average closing price of at least $8 per share over 20 consecutive trading days. One tranche vests after the third anniversary and upon achieving an average closing price of at least $10 per share over 20 consecutive trading days, in each case subject to the reporting person's continued service to the Company.